ArticleChinese medical journal2019

First-line atezolizumab plus chemotherapy in treatment of extensive small cell lung cancer: a cost-effectiveness analysis from China.

Ling-Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.